Cetermin

N/A

Report date: 2022/01/24 13:25:43

Base Information

Drug NameCetermin
Drug Alias NameBetakineTGF-beta-2Transforming growth factor-beta-2Recombinant transforming growth factor-beta-2
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionTransforming growth factor beta receptor 2 inhibitors
TargetsTransforming growth factor beta receptor 2
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesSkin Diseases +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnzon Pharmaceuticals IncInsmed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsmedEnzon Pharmaceuticals IncGenzyme Corp
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune DiseasesSkin Diseases +[9] 

Other Information

ATC CodeN/A
Related LinksN/A